A macrocyclic kinase inhibitor overcomes triple resistant mutations in EGFR-positive lung cancer
大环激酶抑制剂可克服 EGFR 阳性肺癌的三重耐药突变
期刊:npj Precision Oncology
影响因子:6.8
doi:10.1038/s41698-024-00542-9
Mai Suzuki #, Ken Uchibori #, Tomoko Oh-Hara, Yumi Nomura, Ryusei Suzuki, Ai Takemoto, Mitsugu Araki, Shigeyuki Matsumoto, Yukari Sagae, Mutsuko Kukimoto-Niino, Yusuke Kawase, Mikako Shirouzu, Yasushi Okuno, Makoto Nishio, Naoya Fujita, Ryohei Katayama